FDA 483 - Lupin Limited - November 21, 2025

The provided request for a concise summary of an FDA 483 document cannot be fulfilled as the actual content of the 19-page document was not supplied. To generate a summary including the company name, inspection dates, main violations/issues, regulatory framework, and required actions, the full text of the FDA 483 document is necessary. Please provide the document content for a comprehensive summary.